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Background
Currently accepted classifications of pneumonia include
community acquired pneumonia (CAP), healthcare-
associated pneumonia (HCAP), hospital-acquired pneu-
monia (HAP), and ventilator-associated pneumonia
(VAP). Previous studies have shown a high rate of patients
with HCAP or HAP caused by multidrug-resistant bacteria
(MDR). Our aim was to determine the differences in etiol-
ogy and antibiotic-resistant bacteria between CAP, HCAP
and HAP groups.
Methods
We performed a retrospective study in which we included
patients over 18 years old, with culture-positive pneumo-
nia, between 2008 and 2011, from 3 clinical hospitals. The
patients were classified as having CAP, HCAP or HAP.
We recorded the bacteriologic results for the following
samples: blood culture, sputum, bronchial aspirate,
bronchoalveolar lavage. The statistical analysis was carried
out using Graph Pad Prism 5.
Results
A total of 340 patients were recorded (160 with CAP, 39
with HCAP and 141 with HAP). Streptococcus pneumo-
niae and Haemophilus influenzae were seen more
frequently in CAP (33%, 14.4%) than in HCAP or HAP
(1.4%, 0%; p<0.0001). The most common pathogens in
HAP were MRSA (27.7%), Acinetobacter spp. (26.2%),
Klebsiella pneumoniae (19%). Compared to the HCAP,
Acinetobacter spp. and MRSA were significantly associated
with HAP (OR 54.8, p<0.0001, LR 3.9). Compared to the
HAP P aeruginosa and E coli were more common in
HCAP (36%, p 0.04, OR 2; respectively 23%, p 0.001,
OR 7). Among Gram-negative bacilli, resistance to ceftazi-
dime was higher (86%) and significantly associated with
HAP (OR 14.3, p<0.0001, LR 2.7). The extended-spectrum
b-lactamase-producing Enterobacteriaceae, were more
frequent in HAP (67.7%). However, no differences were
found regarding ESBL producing Enterobacteriaceae
between HAP and HCAP (p=0.06). MDR bacteria, including
MRSA and gram-negative bacilli, were identified more fre-
quently in HAP versus HCAP (78.7% vs. 12.8%; p<0.0001,
OR 25, LR 6).
Conclusion
S pneumoniae was the main causative pathogen in CAP.
Despite the higher frequency of P aeruginosa in the HCAP
group, the MDR bacteria were associated with the HAP
group. Our results reveal important differences between
HAP and HCAP concerning the etiology and antibiotic
resistance patterns.
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